A review of 13 medicines mentioning macular degeneration in Australia found all had inappropriately referenced the disease, prompting the health regulator to urge suppliers of listed medicines with eye health indications to reassess their compliance. Read more
Glaukos’ new intraocular implant iDose is on track to complete US Food and Drug Administration trials in 2022, as the company seeks to address glaucoma treatment adherence. Read more
MiSight 1 day, the world’s first daily disposable contact lens for myopia management, recently became the first and only US Food and Drug Administration-approved product clinically proven to slow the progression of myopia. Read more
Optical Supply of Australia (OSA) has unveiled the EasyWork lens, designed to cater for modern-day demands on near and mid-distance vision. Read more
The Advanced Ultravit High Speed Beveled vitrectomy probe is the next evolution of the vitrectomy probes from Alcon. Read more
Menicon Australia is now distributing the new Miru 1day Flat Pack, a user-friendly packaging design that aims to address the challenges of daily disposable lens wear. Read more
Transitions Optical has responded to consumer demand for a photochromic lens that features faster fade back without compromising lens darkness, with the launch of its next-generation Transitions Signature lenses. Read more
A biopharmaceutical company that is developing cheaper anti-VEGF treatments for major global markets, including Australia, has reported positive results from a Phase 3 clinical trial for its Lucentis biosimilar. Read more
The Rodenstock DNEye scanner 2 transfers more than 7,000 measuring points into the individual lens. Read more
Device Technologies Australia and Topcon Healthcare have announced the release and regulatory approval of Topcon Harmony. Read more